I do not see anything like that. It is trading games and who can provide the juice. Just about money. Musk could kill shorts early on because he would buy $20 million worth when they attacked his company. Every time they hit TSLA he hit them harder with buying shares or PR he didn’t mind getting fined by the SEC for.
With small biotech shorts run the tables. Since most fail and quite periods are excruciatingly long. Shorts just put out trash and lash onto any false claim for a lawsuit. The big finale for them is suing the BOD and officials of the company. Then they are all personally liable and dependent upon their insurance firm representing them in court. And AF can constantly hammer away at any company this small because in the beginning the odds of success are extremely small and he can claim he is a Biotech analysis god. I think at this point there is more than enough information acquired over the years to feel strong about NWBO success.
Market Data 
Markets 
AI
